Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy

Ahmed, Ziyan; Sherin, Rinsha P V; Fonseca, Tatiana L.; Hoang, Thanh D.; Shakir, Mohamed K M

doi:10.1002/ccr3.5651

Cited by 2 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Shakir et al [ 50 ] compared the treatment efficiency among LT4, LT4+LT3, and desiccated thyroid extract (DTE) and found similar outcomes among hypothyroid patients treated with LT4, LT4+LT3, and DTE; furthermore, the patients who were most symptomatic on LT4 preferred and responded positively to therapy with LT4+LT3 or DTE. A male patient with treatment-resistant depression and hypothyroidism responded to LT3/LT4 combination therapy, rather than LT4 alone, and he had a DIO2 polymorphism [ 51 ]. Wolff et al [ 52 ] also addressed the problem of developing an optimal TH replacement strategy for hypothyroid patients and reported that LT3/LT4 combined therapy was slightly better than LT4 monotherapy for treating hypothyroidism.…”

Section: Physiological Functions Of Dio2mentioning

confidence: 99%

The Physiological Functions and Polymorphisms of Type II Deiodinase

Deng¹,

Han²,

Gao³

et al. 2023

Endocrinol Metab

View full text Add to dashboard Cite

Type II deiodinase (DIO2) is thought to provide triiodothyronine (T3) to the nucleus to meet intracellular needs by deiodinating the prohormone thyroxine. DIO2 is expressed widely in many tissues and plays an important role in a variety of physiological processes, such as controlling T3 content in developing tissues (e.g., bone, muscles, and skin) and the adult brain, and regulating adaptive thermogenesis in brown adipose tissue (BAT). However, the identification and cloning of DIO2 have been challenging. In recent years, several clinical investigations have focused on the Thr92Ala polymorphism, which is closely correlated with clinical syndromes such as type 2 diabetes, obesity, hypertension, and osteoarthritis. Thr92Ala-DIO2 was also found to be related to bone and neurodegenerative diseases and tumors. However, relatively few reviews have synthesized research on individual deiodinases, especially DIO2, in the past 5 years. This review summarizes current knowledge regarding the physiological functions of DIO2 in thyroid hormone signaling and adaptive thermogenesis in BAT and the brain, as well as the associations between Thr92Ala-DIO2 and bone and neurodegenerative diseases and tumors. This discussion is expected to provide insights into the physiological functions of DIO2 and the clinical syndromes associated with Thr92Ala-DIO2.

show abstract

Section: Physiological Functions Of Dio2mentioning

confidence: 99%